{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:03:06Z","timestamp":1790424186894,"version":"4.1.0"},"reference-count":40,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001870","name":"Foundation for Polish Science","doi-asserted-by":"crossref","award":["Homing Plus grant\/2013-8\/4"],"award-info":[{"award-number":["Homing Plus grant\/2013-8\/4"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Centre, Poland","award":["2015\/16\/S\/NZ6\/00041"],"award-info":[{"award-number":["2015\/16\/S\/NZ6\/00041"]}]},{"name":"National Science Centre, Poland","award":["2016\/21\/B\/NZ5\/01901"],"award-info":[{"award-number":["2016\/21\/B\/NZ5\/01901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00005-018-0513-y","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T06:19:36Z","timestamp":1525846776000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-\u03b1 Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients"],"prefix":"10.2478","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-6130","authenticated-orcid":false,"given":"Marzena","family":"Ciechomska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Merdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Zarecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Swierkot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Gluszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Bogunia-Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wlodzimierz","family":"Maslinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrrheum.2010.81","volume":"6","author":"I Alevizos","year":"2010","unstructured":"Alevizos I, Illei GG (2010) MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6:391\u2013398","journal-title":"Nat Rev Rheumatol"},{"key":"513_CR3","doi-asserted-by":"crossref","unstructured":"Araki Y, Mimura T (2017) Matrix metalloproteinase gene activation resulting from disordred epigenetic mechanisms in rheumatoid arthritis. Int J Mol Sci 18. pii: E905","DOI":"10.3390\/ijms18050905"},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/rheumatology\/keu132","volume":"53","author":"C Bao","year":"2014","unstructured":"Bao C, Huang F, Khan MA et al (2014) Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial. Rheumatology 53:1654\u20131663","journal-title":"Rheumatology"},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","volume":"2","author":"FM Brennan","year":"1989","unstructured":"Brennan FM, Chantry D, Jackson A et al (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244\u2013247","journal-title":"Lancet"},{"key":"513_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-015-0555-z","volume":"17","author":"C Castro-Villegas","year":"2015","unstructured":"Castro-Villegas C et al (2015) Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFalpha. Arthritis Res Ther 17:49","journal-title":"Arthritis Res Ther"},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/rheumatology\/41.5.484","volume":"41","author":"AI Catrina","year":"2002","unstructured":"Catrina AI, Lampa J, Ernestam S et al (2002) Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology 41:484\u2013489","journal-title":"Rheumatology"},{"key":"513_CR8","doi-asserted-by":"publisher","first-page":"e1326","DOI":"10.1097\/MD.0000000000001326","volume":"94","author":"XM Chen","year":"2015","unstructured":"Chen XM, Huang QC, Yang SL et al (2015) Role of micro RNAs in the pathogenesis of rheumatoid arthritis: novel perspectives based on review of the literature. Medicine 94:e1326","journal-title":"Medicine"},{"key":"513_CR9","doi-asserted-by":"crossref","unstructured":"Ciechomska M, O\u2019Reilly S (2016) Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases. Mediators Inflamm 2016:9607946","DOI":"10.1155\/2016\/9607946"},{"key":"513_CR10","doi-asserted-by":"publisher","first-page":"e115596","DOI":"10.1371\/journal.pone.0115596","volume":"9","author":"M Ciechomska","year":"2014","unstructured":"Ciechomska M, O\u2019Reilly S, Suwara M et al (2014) MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One 9:e115596","journal-title":"PLoS One"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/eci.12776","volume":"47","author":"M Ciechomska","year":"2017","unstructured":"Ciechomska M, Zarecki P, Merdas M et al (2017) The role of microRNA-5196 in the pathogenesis of systemic sclerosis. Eur J Clin Invest 47:555\u2013564","journal-title":"Eur J Clin Invest"},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","volume":"33","author":"JR Curtis","year":"2011","unstructured":"Curtis JR, Singh JA (2011) Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther 33:679\u2013707","journal-title":"Clin Ther"},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2199-9-76","volume":"9","author":"PA Davoren","year":"2008","unstructured":"Davoren PA, McNeill RE, Lowery AJ et al (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9:76","journal-title":"BMC Mol Biol"},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"e0161306","DOI":"10.1371\/journal.pone.0161306","volume":"11","author":"P Dey","year":"2016","unstructured":"Dey P, Panga V, Raghunathan S (2016) A cytokine signalling network for the regulation of inducible nitric oxide synthase expression in rheumatoid arthritis. PLoS One 11:e0161306","journal-title":"PLoS One"},{"issue":"4","key":"513_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/genes8040127","volume":"8","author":"M Dolcino","year":"2017","unstructured":"Dolcino M, Tinazzi E, Pelosi A et al (2017) Gene expression analysis before and after treatment with adalimumab in patients with ankylosing spondylitis identifies molecular pathways associated with response to therapy. Genes 8(4):127","journal-title":"Genes"},{"issue":"13 Suppl","key":"513_CR16","first-page":"S295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18(13 Suppl):S295\u2013S302","journal-title":"Am J Manag Care"},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13075-016-1023-0","volume":"18","author":"V Hruskova","year":"2016","unstructured":"Hruskova V, Jandova R, Vernerova L et al (2016) MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis. Arthritis Res Ther 18:124","journal-title":"Arthritis Res Ther"},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, Davis JC Jr, Dv H et al (2008) Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 58:3402\u20133412","journal-title":"Arthritis Rheum"},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5114\/reum.2016.60216","volume":"54","author":"A Klak","year":"2016","unstructured":"Klak A, Raciborski F, Samel-Kowalik P (2016) Social implications of rheumatic diseases. Reumatologia 54:73\u201378","journal-title":"Reumatologia"},{"key":"513_CR20","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang L, Liu F et al (2015) Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma. Dis Markers 2015:893594","DOI":"10.1155\/2015\/893594"},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"e3325","DOI":"10.1097\/MD.0000000000003325","volume":"95","author":"Z Li","year":"2016","unstructured":"Li Z, Wong SH, Shen J et al (2016) The role of MicroRNAS in ankylosing spondylitis. Medicine 95:e3325","journal-title":"Medicine"},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3892\/ijo.2016.3453","volume":"48","author":"J Liao","year":"2016","unstructured":"Liao J, Liu R, Shi YJ et al (2016) Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer. Int J Oncol 48:2567\u20132579","journal-title":"Int J Oncol"},{"key":"513_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s13277-014-2622-5","volume":"36","author":"J Liu","year":"2015","unstructured":"Liu J, Yan J, Zhou C et al (2015) miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma. Tumour Biol 36:219\u2013225","journal-title":"Tumour Biol"},{"key":"513_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane LA, Murphy PR (2010) MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11:537\u2013561","journal-title":"Curr Genomics"},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5312\/wjo.v5.i4.516","volume":"5","author":"L Magyari","year":"2014","unstructured":"Magyari L, Varszegi D, Kovesdi E et al (2014) Interleukins and interleukin receptors in rheumatoid arthritis: research, diagnostics and clinical implications. World J Orthop 5:516\u2013536","journal-title":"World J Orthop"},{"issue":"Suppl 2","key":"513_CR26","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1186\/ar549","volume":"4","author":"RN Maini","year":"2002","unstructured":"Maini RN, Feldmann M (2002) How does infliximab work in rheumatoid arthritis? Arthritis Res 4(Suppl 2):S22\u2013S28","journal-title":"Arthritis Res"},{"key":"513_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172\u20131187","journal-title":"Cell"},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"e0152362","DOI":"10.1371\/journal.pone.0152362","volume":"11","author":"SC Nair","year":"2016","unstructured":"Nair SC, Welsing PM, Choi IY et al (2016) A personalized approach to biological therapy using prediction of clinical response based on MRP8\/14 serum complex levels in rheumatoid arthritis patients. PLoS One 11:e0152362","journal-title":"PLoS One"},{"key":"513_CR29","doi-asserted-by":"publisher","first-page":"25066","DOI":"10.1038\/srep25066","volume":"6","author":"S O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly S, Ciechomska M, Fullard N et al (2016) IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics. Sci Rep 6:25066","journal-title":"Sci Rep"},{"key":"513_CR30","doi-asserted-by":"publisher","first-page":"e0185323","DOI":"10.1371\/journal.pone.0185323","volume":"12","author":"K Prajzlerova","year":"2017","unstructured":"Prajzlerova K, Grobeln\u00e1 K, Hu\u0161\u00e1kov\u00e1 M et al (2017) Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS One 12:e0185323","journal-title":"PLoS One"},{"key":"513_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1177\/0961203311418706","volume":"20","author":"Z Rezaieyazdi","year":"2011","unstructured":"Rezaieyazdi Z, Sahebari M, Hatef MR et al (2011) Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? Lupus 20:1494\u20131500","journal-title":"Lupus"},{"key":"513_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"513_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/ard.2009.126714","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Wong J, Scott DL et al (2010) Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:995\u20131003","journal-title":"Ann Rheum Dis"},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/leu.2011.105","volume":"25","author":"D Schotte","year":"2011","unstructured":"Schotte D, Akbari Moqadam F, Lange-Turenhout EA et al (2011) Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 25:1389\u20131399","journal-title":"Leukemia"},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1365-2125.2001.00321.x","volume":"51","author":"HE Seymour","year":"2001","unstructured":"Seymour HE, Worsley A, Smith JM et al (2001) Anti-TNF agents for rheumatoid arthritis. Br J Clin Pharmacol 51:201\u2013208","journal-title":"Br J Clin Pharmacol"},{"key":"513_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/gene.2013.69","volume":"15","author":"K Smigielska-Czepiel","year":"2014","unstructured":"Smigielska-Czepiel K, van den Berg A, Jellema P et al (2014) Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun 15:115\u2013125","journal-title":"Genes Immun"},{"key":"513_CR37","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.065","author":"CN Son","year":"2017","unstructured":"Son CN, Lee TH, Bang JH et al (2017) The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus. Korean J Intern Med. \n                    https:\/\/doi.org\/10.3904\/kjim.2016.065","journal-title":"Korean J Intern Med"},{"key":"513_CR38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","volume":"5","author":"PC Taylor","year":"2009","unstructured":"Taylor PC, Feldmann M (2009) Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 5:578\u2013582","journal-title":"Nat Rev Rheumatol"},{"key":"513_CR39","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1159\/000447869","volume":"39","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang H, Jiang J et al (2016) Comparative efficacy and acceptability of anti-TNF-alpha therapy in ankylosing spondylitis: a mixed-treatments comparison. Cell Physiol Biochem 39:1679\u20131694","journal-title":"Cell Physiol Biochem"},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-017-0260-7","volume":"10","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li M, Ding Y et al (2017) Serum microRNA profile in patients with colon adenomas or cancer. BMC Med Genom 10:23","journal-title":"BMC Med Genom"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-018-0513-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:07Z","timestamp":1704228547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-018-0513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s00005-018-0513-y","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}